Theophylline formulation by supercritical antisolvents

International Journal of Pharmaceutics

Volumn 343, Issue 1-2, 2007, Pages 79-89

  Roy, Christelle ^a   Vega González, Arlette ^a   Subra Paternault, Pascale ^a  

^a UNIVERSITÉ PARIS 13   (France)

Author keywords

Controlled release; Crystals; Fluoroform; Formulation; Supercritical fluids; Theophylline

Indexed keywords

CARBON DIOXIDE; FLUOROFORM; POLYLACTIC ACID; THEOPHYLLINE;

ARTICLE; BATCH PROCESS; CRYSTAL STRUCTURE; DISSOLUTION; DRUG FORMULATION; DRUG RELEASE; HYDRATION; KINETICS; POWDER; PRECIPITATION; PRIORITY JOURNAL; X RAY DIFFRACTION;

CARBON DIOXIDE; CHEMISTRY, PHARMACEUTICAL; CHLOROFLUOROCARBONS, METHANE; DELAYED-ACTION PREPARATIONS; MICROSCOPY, ELECTRON, SCANNING; PARTICLE SIZE; POWDER DIFFRACTION; SOLUBILITY; THEOPHYLLINE; X-RAY DIFFRACTION;

EID: 34548245167     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2007.05.008     Document Type: Article

References (36)

1. Airaksinen S., Karjalainen M., Räsänen E., Rantanen J., and Yliruusi J. Comparison of the effects of two drying methods on polymorphism of theophylline. Int. J. Pharm. 276 (2004) 129-141
2. Airaksinen S., Luukkonen P., Jorgensen A., Karjalainen M., Rantanen J., and Yliruusi J. Effects of excipients on hydrate formation in wet masses containing theophylline. J. Pharm. Sci. 92 (2003) 516-528
3. ® on the properties of lipid controlled release microparticles. J. Controlled Release 100 (2004) 233-246
4. Ando H., Ishii M., Kayano M., and Ozawa H. Effect of moisture on crystallization of theophylline in tablets. Drug Dev. Ind. Pharm. 18 (1992) 453-467
5. Antal I., Zelko R., Röczey N., Plachy J., and Racz I. Dissolution and diffuse reflectance characteristics of coated theophylline particles. Int. J. Pharm. 155 (1997) 83-89
6. Asada M., Takahashi H., Okamoto H., Tanino H., and Danjo K. Theophylline particles design using chitosan by the spray drying. Int. J. Pharm. 270 (2004) 167-174
7. Boutin O., Badens E., Carretier E., and Charbit G. Co-precipitation of a herbicide and biodegradable materials by the supercritical anti-solvent technique. J. Supercrit. Fluids 31 (2004) 89-99
8. Caliceti P., Salmaso S., Elvassore N., and Bertucco A. Effective protein release from PEG/PLA nano-particles produced by compressed gas anti-solvent precipitation techniques. J. Controlled Release 94 (2004) 195-205
9. Ceballos A., Cirri M., Mastrelli F., Certi C., and Mura P. Influence of formulation and process variables on in vitro release of theophylline from directly compressed Eudragit matrix tablets. Il Farmaco 60 (2005) 913-918
10. Corrigan O.I., and Crean A.M. Comparative physicochemical properties of hydrocortisone-PVP composites prepared using supercritical carbon dioxide by the GAS anti-solvent recrystallization process, by coprecipitation and by spray drying. Int. J. Pharm. 245 (2002) 75-82
11. De Gioannis B., Jestin P., and Subra P. Morphology and growth of griseofulvin recrystallized by compressed carbon dioxide as antisolvent. J. Crystal Growth 262 (2004) 519-526
12. Dehghani F., and Foster N.R. Dense gas anti-solvent processes for pharmaceutical formulation. Curr. Opin. Solid State Mater. Sci. 7 (2003) 363-369
13. Duarte A.R.C., Roy C., Vega-González A., Duarte C.M.M., and Subra-Paternault P. Preparation of acetazolamide composite microparticles by supercritical antisolvent techniques. Int. J. Pharm. 332 (2007) 132-139
14. Gohel M.C., Jani G.K., Amin A.F., Patel K.V., and Gupta S.V. Application of classical experimental design for the development of theophylline microspheres. J. Controlled Release 45 (1997) 265-271
15. Gong K., Viboonkiat R., Rehman I.U., Buckton G., and Darr J.A. Formation and characterization of porous indomethacin-PVP coprecipitates prepared using solvent-free supercritical fluid processing. J. Pharm. Sci. 94 (2005) 2583-2590
16. Leadi Cole M., and Wateley T.L. Release rate profiles of theophylline and insulin from stable multiple w/o/w emulsions. J. Controlled Release 49 (1997) 51-58
17. Leuner C., and Dressman J. Improving drug solubility for oral delivery using solid dispersion. Eur. J. Pharm. Biopharm. 50 (2000) 47-60
18. Lin W.-J., and Lee H.-G. Design of a microporous controlled delivery system for theophylline tablets. J. Controlled Release 89 (2003) 179-187
19. Liu J., Lin S., and Liu E. Release of theophylline from polymer blend hydrogels. Int. J. Pharm. 298 (2005) 117-125
20. Mengozzi G., Intorre L., Bertini S., Giorgi M., and Soldani G. Comparative bioavailability of two sustained-release theophylline formulations in the dog. Pharm. Res. 38 (1998) 481-485
21. Moneghini M., Perissutti B., Kikic I., Grassi M., Cortesi A., and Princivalle F. Preparation of theophylline-hydroxypropylmethylcellulose matrices using supercritical antisolvent precpitation: a preliminary study. Drug Dev. Ind. Pharm. 32 (2006) 39-52
22. Nair S.R., and Watson J.P. Suicidal ideation caused by theophylline toxicity-a case report. Respir. Med. Extra 1 (2005) 13-15
23. Parvez N., Ahmed T., Monif T., Saha N., and Sharma P.L. Comparative bioavailability of three oral formulations of sustained release theophylline in healthy human subjects. Int. J. Pharm. 36 (2004) 29-33
24. Perrut M., Jung J., and Leboeuf F. Enhancement of dissolution rate of poorly-soluble active ingredients by supercritical fluid processes. Part I: micronization of neat particles. Int. J. Pharm. 288 (2005) 3-10
25. Phadnis N.V., and Suryanarayanan R. Polymorphism in anhydrous theophylline-implications on the dissolution rate of theophylline tablets. J. Pharm. Sci. 86 (1997) 1256-1263
26. Rasanen E., Rantanen J., Jorgensen A., Karjalainen M., Paakkari T., and Yliruusi J. Novel identification of pseudopolymorphismic changes of theophylline during wet granulation using near infrared spectroscopy. J. Pharm. Sci. 90 (2001) 389-396
27. Ritger P., and Peppas N. A simple equation for description of solute release. I. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs. J. Controlled Release 5 (1987) 23-36
28. Rodrigues M., Peiriço N., Matos H., Gomes de Azevedo E., Lobato M.R., and Almeida A.J. Microcomposites theophylline/hydrogenated palm oil from a PGSS process for controlled drug delivery systems. J. Supercrit. Fluids 29 (2004) 175-184
29. Roy C., Vega-González A., and Subra-Paternault P. Batch and semi-continuous techniques for the precipitation of theophylline. ISASF Proceedings IBN 2-905267-47-X, 10th European Meeting on Supercritical Fluids. Colmar-France December (2005)
30. Siepmann J., and Peppas N.A. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv. Drug Delivery Rev. 48 (2001) 139-157
31. Subra P., and Jestin P. Powders elaboration in supercritical media: comparison with conventional routes. Powders Technol. 103 (1999) 2-9
32. 2 mixtures. J. Supercrit. Fluids 35 (2005) 95-105
33. Taki S., Badens E., and Charbit G. Controlled release system formed by supercritical anti-solvent coprecipitation of a herbicide and a biodegradable polymer. J. Supercrit. Fluids 21 (2001) 61-70
34. Vega-González A., Domingo C., Elvira C., and Subra P. Precipitation of PMMA/PCL blends using supercritical carbon dioxide. J. Appl. Polym. Sci. 91 (2004) 2422-2426
35. Zacchigna M., Di Luca G., Cateni F., Zorzet S., and Maurich V. Improvement of physicochemical and biopharmaceutical properties of theophylline by poly(ethylene glycol) conjugates. Il Farmaco 58 (2003) 1307-1312
36. Zhu H., Yuen C., and Grant D. Influence of water activity in organic solvent + water mixtures on the nature of the crystallizing drug phase 1. Theophylline. Int. J. Pharm. 135 (1996) 151-160